[go: up one dir, main page]

TN2009000495A1 - Macrocycles and their uses - Google Patents

Macrocycles and their uses

Info

Publication number
TN2009000495A1
TN2009000495A1 TNP2009000495A TN2009000495A TN2009000495A1 TN 2009000495 A1 TN2009000495 A1 TN 2009000495A1 TN P2009000495 A TNP2009000495 A TN P2009000495A TN 2009000495 A TN2009000495 A TN 2009000495A TN 2009000495 A1 TN2009000495 A1 TN 2009000495A1
Authority
TN
Tunisia
Prior art keywords
macrocycles
amelioration
diseases
prevention
useful
Prior art date
Application number
TNP2009000495A
Other languages
English (en)
Inventor
Roger Aki Fujimoto
Philipp Krastel
Matthew J Lamarche
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2009000495A1 publication Critical patent/TN2009000495A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNP2009000495A 2007-06-04 2009-11-26 Macrocycles and their uses TN2009000495A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94177707P 2007-06-04 2007-06-04
PCT/EP2008/056838 WO2008148754A2 (fr) 2007-06-04 2008-06-03 Macrocycles et leurs utilisations

Publications (1)

Publication Number Publication Date
TN2009000495A1 true TN2009000495A1 (en) 2011-03-31

Family

ID=40094226

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000495A TN2009000495A1 (en) 2007-06-04 2009-11-26 Macrocycles and their uses

Country Status (24)

Country Link
US (2) US8476224B2 (fr)
EP (1) EP2170907A2 (fr)
JP (1) JP2010529076A (fr)
KR (1) KR101202483B1 (fr)
CN (1) CN101772506B (fr)
AR (1) AR066865A1 (fr)
AU (1) AU2008258639B2 (fr)
BR (1) BRPI0812340A2 (fr)
CA (1) CA2688621A1 (fr)
CL (1) CL2008001613A1 (fr)
CO (1) CO6270222A2 (fr)
CR (1) CR11158A (fr)
EA (1) EA200901613A1 (fr)
EC (1) ECSP099836A (fr)
GT (1) GT200900310A (fr)
IL (1) IL202285A0 (fr)
MA (1) MA31562B1 (fr)
MX (1) MX2009013214A (fr)
NZ (1) NZ581917A (fr)
PE (1) PE20090318A1 (fr)
TN (1) TN2009000495A1 (fr)
TW (1) TW200902540A (fr)
WO (1) WO2008148754A2 (fr)
ZA (1) ZA200908262B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY156466A (en) 2007-12-12 2016-02-26 Novartis Ag Aminothiazoles and their uses
EP3528786B1 (fr) * 2016-10-21 2023-04-05 Xellia Pharmaceuticals ApS Formulations liquides de daptomycine
CN109485617B (zh) * 2018-12-11 2023-01-31 贵州永诺菲特生物制药有限公司 一种n-甲基-2-异丙基-4-噻唑甲胺的制备方法
WO2024044751A2 (fr) * 2022-08-26 2024-02-29 Wake Forest University Health Sciences Inhibiteurs de peroxyrédoxine 3 et procédés d'utilisation pour le traitement du cancer
WO2025038747A1 (fr) * 2023-08-14 2025-02-20 Rs Oncology, Llc Composés inspirés du thiostrepton modifiés pour le traitement du cancer et leur préparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69108972T2 (de) 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
DE9004073U1 (de) 1990-04-07 1990-06-13 Auto-Kabel Hausen GmbH & Co. Betriebs-KG, 79688 Hausen Anschlußklemme für Akkumulator o.dgl.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DE69224497T2 (de) 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
EP0880541B1 (fr) 1996-02-14 2003-01-15 Biosearch Italia S.p.A. Derives des facteurs de l'antibiotique ge2270
JPH1059997A (ja) * 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
BR0305070A (pt) * 2002-06-17 2004-09-21 Vicuron Pharm Inc Uso de derivado amida de ge 2270 fator a3 para tratamento da acne
US20050106159A1 (en) * 2003-08-12 2005-05-19 Thompson Stuart A. Campylobacter jejuni outer membrane protein immunogenic composition
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
WO2008082562A2 (fr) * 2006-12-20 2008-07-10 Novartis Ag Composés anti-bactériens et leurs procédés de fabrication

Also Published As

Publication number Publication date
TW200902540A (en) 2009-01-16
CL2008001613A1 (es) 2009-05-15
CN101772506B (zh) 2014-02-12
AU2008258639B2 (en) 2012-07-05
KR101202483B1 (ko) 2012-11-16
PE20090318A1 (es) 2009-04-17
ECSP099836A (es) 2010-01-29
AR066865A1 (es) 2009-09-16
CA2688621A1 (fr) 2008-12-11
MX2009013214A (es) 2010-01-15
NZ581917A (en) 2011-04-29
KR20100021496A (ko) 2010-02-24
US8691756B2 (en) 2014-04-08
CR11158A (es) 2010-01-20
AU2008258639A1 (en) 2008-12-11
US20130252883A1 (en) 2013-09-26
ZA200908262B (en) 2010-08-25
WO2008148754A2 (fr) 2008-12-11
WO2008148754A3 (fr) 2009-03-05
EA200901613A1 (ru) 2010-06-30
BRPI0812340A2 (pt) 2015-01-27
US8476224B2 (en) 2013-07-02
GT200900310A (es) 2010-05-21
MA31562B1 (fr) 2010-08-02
IL202285A0 (en) 2010-06-16
EP2170907A2 (fr) 2010-04-07
JP2010529076A (ja) 2010-08-26
CN101772506A (zh) 2010-07-07
US20090186830A1 (en) 2009-07-23
CO6270222A2 (es) 2011-04-20

Similar Documents

Publication Publication Date Title
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TNSN08400A1 (en) Organic compounds and their uses
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
TN2011000482A1 (en) Organic compounds and their uses
JO3235B1 (ar) مركبات بيررولوبيريميدين و استعمالاتها
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
WO2008124660A3 (fr) Procédés et compositions pour le traitement du cancer
WO2007095638A3 (fr) Petites molecules contenant du bore en tant qu'agents anti-inflammatoires
SG170813A1 (en) New compounds
TW200801021A (en) Imidazolothiazole compounds for the treatment of disease
MX2009006535A (es) Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina.
MX2009004047A (es) Compuestos organicos.
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
WO2007121125A3 (fr) Composés organiques et leurs utilisations
TNSN08496A1 (en) Aminothiazoles and their uses
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
WO2010074936A3 (fr) Enzastaurine dans le traitement du cancer
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
EP2207555A4 (fr) Nouveaux composés pour le traitement ou l'atténuation des oedèmes, et leurs méthodes d'utilisation
TN2009000495A1 (en) Macrocycles and their uses
WO2010037095A3 (fr) Agents et procédés pour le traitement du cancer
WO2008033389A3 (fr) Composés organiques et leurs utilisations
MX2009009693A (es) Metodos para activar irs-1 y akt.
CL2008001837A1 (es) Uso de compuestos derivados de cinolin-3-carboxamida en el tratamiento de la esquizofrenia.